KYAN Therapeutics' technology platform identifies novel and effective nucleic acid therapies for MYC-driven liver cancer

… in Bioengineering & Translational Medicine SINGAPORE, SINGAPORE, September 17, 2022 /⁨EINPresswire … a two-drug combination of novel splice-switch oligonucleotides (SSOs) as … and the National University of Singapore, combining small data AI and …